[Vasodilating-acting antihypertensive agents: model substance sodium nitroprusside].
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D002118:Calcium / Q000378:metabolism; D005292:Ferricyanides / Q000627:therapeutic use*; D006207:Half-Life; D006321:Heart / Q000187:drug effects; D006973:Hypertension / Q000188:drug therapy*; D009130:Muscle, Smooth / Q000187:drug effects; D009599:Nitroprusside / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000009:adverse effects / Q000627:therapeutic use*
D005292:Ferricyanides; D014665:Vasodilator Agents; D009599:Nitroprusside; D002118:Calcium
Vasodilatatorisch wirkende Antihypertensiva: Modellsubstanz Natrium-Nitroprussid.